Drug Trial Radar · NCT04313244
Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years
Last checked: Nov 19, 2026Latest source record: Feb 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
614
Actual
Start
May 15, 2021
Primary completion
Feb 21, 2022
Study completion Jul 19, 2022
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 14 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to demonstrate the non-inferiority (NI) of the immune response to 2 doses of 9vHPV vaccine, 1 co-administered with TDV, compared with 2 doses of 9vHPV vaccine administered alone.
Conditions
- Dengue Fever
Interventions
9vHPV VaccineBiological
9vHPV intramuscular injection
Dengue Tetravalent Vaccine (TDV)Biological
TDV subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Titers (GMTs) for Human Papillomavirus (HPV) Types 6, 11, 16, 18, 31, 33, 45, 52, 58Time frame: Day 210 (Month 7)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
The Hospital for Tropical Diseases
Bangkok, Thailand
Thammasat University Hospital
Pathum Thani, Thailand
Siriraj Hospital
Bangkoknoi, Khet Bangkok Noi, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.